Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone

Free Abstracts


  Free Subscription


1 BMC Cancer
41 Br J Dermatol
3 Cancer Res
1 Clin Exp Dermatol
4 Cutis
2 Int J Cancer
2 Intern Med
1 J Dermatol
5 J Invest Dermatol
6 N Engl J Med
2 PLoS One

  Retrieve available abstracts of this week’s articles:
HTML format
Text format
Single Articles

    BMC Cancer

  1. CHAGANI S, Wang R, Carpenter EL, Lohr CV, et al
    Ablation of epidermal RXRalpha in cooperation with activated CDK4 and oncogenic NRAS generates spontaneous and acute neonatal UVB induced malignant metastatic melanomas.
    BMC Cancer. 2017;17:736.
    PubMed     Text format     Abstract available

    Br J Dermatol

  2. BASU TN
    Neutrophilic eccrine hidradenitis can be induced by BRAF inhibitors.
    Br J Dermatol. 2017;176:1443-1444.
    PubMed     Text format    

  3. BOWER C
    Field treatment of actinic keratosis on the scalp.
    Br J Dermatol. 2017;176:1425-1426.
    PubMed     Text format    

  4. LEGAT FJ, Wolf P
    Daylight photodynamic therapy: where and when is it possible?
    Br J Dermatol. 2017;176:1440-1441.
    PubMed     Text format    

  5. PATSATSI A, Murrell DF
    Multiple sclerosis is the neurological disorder most highly associated with bullous pemphigoid.
    Br J Dermatol. 2017;176:1428-1429.
    PubMed     Text format    

    Oxidative stress and high-mobility group box 1 (HMGB1) protein release in vitiligo.
    Br J Dermatol. 2017;176:1436-1437.
    PubMed     Text format    

  7. MURPHY M, Carmichael AJ
    Development of a multidimensional assessment tool for uraemic pruritus in dialysis patients - laying a foundation stone for itch research.
    Br J Dermatol. 2017;176:1432-1433.
    PubMed     Text format    

  8. ITO T
    Immune checkpoint inhibitor-associated alopecia areata.
    Br J Dermatol. 2017;176:1444-1445.
    PubMed     Text format    

  9. DLOVA NC, Dadzie OE
    Frontal Fibrosing Alopecia Severity Index (FFASI): a call for a more inclusive and globally relevant severity index for frontal fibrosing alopecia.
    Br J Dermatol. 2017;177:883-884.
    PubMed     Text format    

  10. TWO AM
    Minocycline as an alternative to doxycycline in the treatment of rosacea.
    Br J Dermatol. 2017;176:1426.
    PubMed     Text format    

    A new clinical diagnostic matrix for epidermolysis bullosa.
    Br J Dermatol. 2017;176:1442-1443.
    PubMed     Text format    

  12. TAN J
    Updating the diagnosis, classification and assessment of rosacea by effacement of subtypes: reply from the author.
    Br J Dermatol. 2017;177:598-599.
    PubMed     Text format    

  13. DEL PUERTO C, Navarrete-Dechent C, Molgo M, Camargo CA Jr, et al
    Immunohistochemical expression of vitamin D receptor in melanocytic nevi and cutaneous melanoma. A case-control study.
    Br J Dermatol. 2017 Nov 6. doi: 10.1111/bjd.16103.
    PubMed     Text format     Abstract available

  14. BURDEN-TEH E, Phillips RC, Thomas KS, Ratib S, et al
    A systematic review of diagnostic criteria for psoriasis in adults and children: Evidence from studies with a primary aim to develop or validate diagnostic criteria.
    Br J Dermatol. 2017 Nov 6. doi: 10.1111/bjd.16104.
    PubMed     Text format     Abstract available

  15. TZANEVA S, Geroldinger A, Trattner H, Tanew A, et al
    Fumaric acid esters in combination with a 6-week course of narrow-band UVB provides for an accelerated response as compared to fumaric acid esters monotherapy in patients with moderate to severe plaque psoriasis: A randomized prospective clinical stud
    Br J Dermatol. 2017 Nov 8. doi: 10.1111/bjd.16106.
    PubMed     Text format     Abstract available

  16. SNAST I, Reiter O, Atzmony L, Leshem YA, et al
    Psychological stress and psoriasis. A systematic review and meta-analysis.
    Br J Dermatol. 2017 Nov 9. doi: 10.1111/bjd.16116.
    PubMed     Text format     Abstract available

    Research questions for the treatment of alopecia areata have been prioritized.
    Br J Dermatol. 2017;176:1128-1129.
    PubMed     Text format    

  18. TAMURA D, Khan SG, DiGiovanna JJ
    Molecular diagnosis of xeroderma pigmentosum variant in an isolated population: the interface between precision medicine and public health.
    Br J Dermatol. 2017;176:1125-1126.
    PubMed     Text format    

    Long methylaminolaevulinate application does not increase clinical efficacy of photodynamic therapy in actinic keratosis, but leads to collateral damage.
    Br J Dermatol. 2017;176:1121-1122.
    PubMed     Text format    

    Prognostic factors in mycosis fungoides: international advances in the validation of prognostic indices.
    Br J Dermatol. 2017;176:1129-1130.
    PubMed     Text format    

  21. CHONG BF
    Pathogenesis of morphoea: knowledge gaps in subtypes and comparisons to systemic sclerosis.
    Br J Dermatol. 2017;177:9-10.
    PubMed     Text format    

  22. HATTA N
    New technology discloses the tumour margin of extramammary Paget disease?
    Br J Dermatol. 2017;177:18-19.
    PubMed     Text format    

  23. CALZAVARA-PINTON PG, Caravello S
    A practical approach to the initial dose and subsequent increments for ultraviolet A1 phototherapy.
    Br J Dermatol. 2017;177:19-20.
    PubMed     Text format    

  24. SHARMA VK, Bhatia R
    Vitiligo and the psyche.
    Br J Dermatol. 2017;177:612-613.
    PubMed     Text format    

  25. EMTESTAM L, Sartorius K
    Glucagon-like peptide-1 agonists for treatment of hidradenitis suppurativa.
    Br J Dermatol. 2017;177:625-627.
    PubMed     Text format    

  26. VOSSEN ARJV, van der Zee HH, Prens EP
    Sequence variants in hidradenitis suppurativa: in search of the pathogenic mechanisms.
    Br J Dermatol. 2017;177:895-896.
    PubMed     Text format    

  27. BETZ RC
    A path through the reticulate pigmentation disorder jungle.
    Br J Dermatol. 2017;177:893-894.
    PubMed     Text format    

  28. YUAN H, Pan M
    Endoscopic characteristics of oesophagus involvement in mucous membrane pemphigoid.
    Br J Dermatol. 2017;177:902-903.
    PubMed     Text format    

  29. TAN J
    Acne guidelines: pearls, pitfalls and questions.
    Br J Dermatol. 2017;177:892-893.
    PubMed     Text format    

  30. ASERO R
    Towards a better categorization of patients with chronic urticaria.
    Br J Dermatol. 2017;177:903-904.
    PubMed     Text format    

  31. SEMINARA NM, Pomeranz MK
    Unravelling the links between malignancy, cytokines and neutrophilic eruptions.
    Br J Dermatol. 2017;177:905-906.
    PubMed     Text format    

  32. PRIOR J
    Qualitative study of online discussion forums about acne.
    Br J Dermatol. 2017;177:616.
    PubMed     Text format    

    Eczema treatment: it takes time to do no harm.
    Br J Dermatol. 2017;177:613-614.
    PubMed     Text format    

  34. RAO S, Arbiser JL
    Promoting intolerance: learning from warts.
    Br J Dermatol. 2017;177:621-622.
    PubMed     Text format    

  35. DAWE RS, McGuire VA
    Mild classical xeroderma pigmentosum.
    Br J Dermatol. 2017;177:21-22.
    PubMed     Text format    

  36. HAMMERS CM, Payne AS
    Clinical significance of immunoglobulin E in bullous pemphigoid.
    Br J Dermatol. 2017;177:13-14.
    PubMed     Text format    

  37. BAGOT M
    Folliculotropic mycosis fungoides is a heterogenous group.
    Br J Dermatol. 2017;177:17-18.
    PubMed     Text format    

  38. HOLMES S, Harries M
    Re: Frontal Fibrosing Alopecia Severity Index (FFASI): a call for a more inclusive and globally relevant severity index for frontal fibrosing alopecia: reply from the authors.
    Br J Dermatol. 2017;177:884.
    PubMed     Text format    

    Psoralen-ultraviolet A maintenance in mycosis fungoides: the underlying question.
    Br J Dermatol. 2017;177:336-337.
    PubMed     Text format    

  40. STEFANAKI C, Stratigos A
    Alopecia in Cronkhite-Canada syndrome.
    Br J Dermatol. 2017;177:348-349.
    PubMed     Text format    

  41. DAWE RS
    Maintenance therapy with psoralen-ultraviolet A for mycosis fungoides: in the absence of evidence sitting on the fence is appropriate.
    Br J Dermatol. 2017;177:337-338.
    PubMed     Text format    

  42. TENSEN CP, Vermeer MH
    MicroRNA-155 potentiates tumour development in mycosis fungoides.
    Br J Dermatol. 2017;177:618-620.
    PubMed     Text format    

    Cancer Res

  43. KATZENELLENBOGEN BS, Zhao Y, Laws MJ, Sanabria Guillen V, et al
    Structurally novel antiestrogens elicit differential responses from constitutively active mutant estrogen receptors in breast cancer cells and tumors.
    Cancer Res. 2017 Sep 13. pii: canres.1265.2017.
    PubMed     Text format     Abstract available

  44. TURCOTTE M, Allard D, Mittal D, Bareche Y, et al
    CD73 Promotes Resistance to HER2/ErbB2 Antibody Therapy.
    Cancer Res. 2017;77:5652-5663.
    PubMed     Text format     Abstract available

  45. VENTURA J, Lobachevsky PN, Palazzolo JS, Forrester H, et al
    Localized Synchrotron Irradiation of Mouse Skin Induces Persistent Systemic Genotoxic and Immune Responses.
    Cancer Res. 2017 Nov 7. doi: 10.1158/0008-5472.CAN-17-1066.
    PubMed     Text format     Abstract available

    Clin Exp Dermatol

  46. SIMON L, Delaunay P, Martinez JP, Hubiche T, et al
    Intensive cutaneous myiasis due to Musca domestica in a patient with Alzheimer disease: a rare larval infestation in a temperate zone.
    Clin Exp Dermatol. 2017 Nov 6. doi: 10.1111/ced.13291.
    PubMed     Text format    


  47. CIZENSKI JD, Farah RS
    Atypical fibroxanthoma arising within erosive pustular dermatosis of the scalp.
    Cutis. 2017;100:E14-E16.
    PubMed     Text format     Abstract available

  48. SILVERBERG NB, Silverberg JI
    The atopic dermatitis biologic era has begun.
    Cutis. 2017;100:145-146.
    PubMed     Text format    

    Atopic dermatitis prevention and treatment.
    Cutis. 2017;100:173.
    PubMed     Text format     Abstract available

  50. RUTT VL, Reed KX, Liu X, Richard EG, et al
    Photosensitive atopic dermatitis exacerbated by UVB exposure.
    Cutis. 2017;100:180-184.
    PubMed     Text format     Abstract available

    Int J Cancer

  51. AITKEN JF, Youlden DR, Baade PD, Soyer HP, et al
    Generational shift in melanoma incidence and mortality in Queensland, Australia, 1995-2014.
    Int J Cancer. 2017 Nov 6. doi: 10.1002/ijc.31141.
    PubMed     Text format     Abstract available

  52. WANG Y, Pfeiffer RM, Alsaggaf R, Meeraus W, et al
    Risk of skin cancer among patients with myotonic dystrophy type 1 based on Primary care physician data from the United Kingdom Clinical Practice Research Datalink.
    Int J Cancer. 2017 Nov 7. doi: 10.1002/ijc.31143.
    PubMed     Text format     Abstract available

    Intern Med

  53. MATSUO S, Hayashi K, Morimoto E, Kato A, et al
    The Successful Treatment of Refractory Polyarteritis Nodosa Using Infliximab.
    Intern Med. 2017;56:1435-1438.
    PubMed     Text format     Abstract available

  54. TOKUNAGA K, Hagino N
    Dermatomyositis with Rapidly Progressive Interstitial Lung Disease Treated with Rituximab: A Report of 3 Cases in Japan.
    Intern Med. 2017;56:1399-1403.
    PubMed     Text format     Abstract available

    J Dermatol

  55. ITO T, Takahashi H, Kawada A, Iizuka H, et al
    Epidemiological survey from 2009 to 2012 of psoriatic patients in Japanese Society for Psoriasis Research.
    J Dermatol. 2017 Nov 8. doi: 10.1111/1346-8138.14105.
    PubMed     Text format     Abstract available

    J Invest Dermatol

  56. LOHCHAROENKAL W, Das Mahapatra K, Pasquali L, Crudden C, et al
    Genome-wide screen for microRNAs reveals a role for miR-203 in melanoma metastasis.
    J Invest Dermatol. 2017 Nov 2. pii: S0022-202X(17)33137.
    PubMed     Text format     Abstract available

  57. OGDIE A, Grewal SK, Noe MH, Shin D, et al
    Risk of incident liver disease in patients with psoriasis, psoriatic arthritis, and rheumatoid arthritis: a population-based study.
    J Invest Dermatol. 2017 Oct 27. pii: S0022-202X(17)33097.
    PubMed     Text format     Abstract available

  58. IMANISHI H, Ansell DM, Cheret J, Harries M, et al
    Epithelial-mesenchymal stem cell transition in a human organ: Lessons from lichen planopilaris.
    J Invest Dermatol. 2017 Oct 26. pii: S0022-202X(17)33083.
    PubMed     Text format     Abstract available

  59. DUANGKHAE P, Erdos G, Ryman KD, Watkins SC, et al
    Interplay between Keratinocytes and Myeloid Cells Drives Dengue Virus Spread in Human Skin.
    J Invest Dermatol. 2017 Oct 26. pii: S0022-202X(17)33090.
    PubMed     Text format     Abstract available

  60. CHIANG A, Jaju PD, Batra P, Rezaee M, et al
    Genomic Stability in Syndromic Basal Cell Carcinoma.
    J Invest Dermatol. 2017 Oct 27. pii: S0022-202X(17)33095.
    PubMed     Text format     Abstract available

    N Engl J Med

    Adjuvant Melanoma Therapy - Head-Spinning Progress.
    N Engl J Med. 2017;377:1888-1890.
    PubMed     Text format    

  62. FUENTES-SUAREZ A, Gonzalez-Marquez TN
    "Acrobatic" Lice.
    N Engl J Med. 2017;377:e19.
    PubMed     Text format    

  63. GREENE AK, Voss SD, Maclellan RA
    Liposuction for Swelling in Patients with Lymphedema.
    N Engl J Med. 2017;377:1788-1789.
    PubMed     Text format    

    N Engl J Med. 2017;377:1754-1764.
    PubMed     Text format    

  65. GOMEZ-MOYANO E, Crespo-Erchiga V
    HIV Infection Manifesting as Proximal White Onychomycosis.
    N Engl J Med. 2017;377:e26.
    PubMed     Text format    

  66. NAROD S, Booth CM, Foulkes WD
    Olaparib for Metastatic Germline BRCA-Mutated Breast Cancer.
    N Engl J Med. 2017;377:1792.
    PubMed     Text format    

    PLoS One

  67. OH S, Yap GC, Hong PY, Huang CH, et al
    Immune-modulatory genomic properties differentiate gut microbiota of infants with and without eczema.
    PLoS One. 2017;12:e0184955.
    PubMed     Text format     Abstract available

  68. HOSOKAWA Y, Masaki N, Takei S, Horikawa M, et al
    Recurrent triple-negative breast cancer (TNBC) tissues contain a higher amount of phosphatidylcholine (32:1) than non-recurrent TNBC tissues.
    PLoS One. 2017;12:e0183724.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Dermatology is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.